47045-MDA-T-PAS-1
The Global Fund to Fight AIDS, Tuberculosis and Malaria
<narrative xml:lang="en">Strengthening Tuberculosis control in the Republic of Moldova - Moldova (01-Jul-2015-31-Dec-2017)</narrative>
Moldova, Tuberculosis, Center for Health Policies and Studies (PAS Center)This program has the following goals: To reduce the burden of tuberculosis (including M/XDR-TB) in Moldova by ensuring universal access to quality diagnosis and treatment, implementing sustainable patient-centered approaches, addressing the needs of high-risk groups and strengthening NTP man. The objectives of this program are: To ensure universal access to timely and quality diagnosis of all forms of TB inclusing MDR/XDR TB. To improve management of HIV-associated TB. To strenghten patient-centered approaches to MDR/XDR treatment
The Global Fund to Fight AIDS, Tuberculosis and Malaria
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies
Center for Health Policies and Studies
Center for Health Policies and Studies
The Global Fund to Fight AIDS, Tuberculosis and Malaria
The Global Fund to Fight AIDS Tuberculosis and Malaria
Communications
Web Team
+41 58 791 1700
website@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
The Global Fund to Fight AIDS Tuberculosis and Malaria
Grant Management Division
Tatiana, VINICHENKO
Fund Portfolio Manager
+41 58 791 1700
tatiana.vinichenko@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
The Global Fund to Fight AIDS Tuberculosis and Malaria
Communications
Web Team
+41 58 791 1700
website@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
Moldova
Tuberculosis
2470492.75
Global Fund Commitment to MDA-T-PASP01.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
2688612.29
Global Fund Commitment to MDA-T-PASP01.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
943123.52
Global Fund Commitment to MDA-T-PASP01.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
-277306.35
Global Fund Commitment to MDA-T-PASP01.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
2210532.25
Global Fund Commitment to MDA-T-PASP01.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
2210532.25
Global Fund disbursement to MDA-T-PASP01.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
421602.32
Global Fund disbursement to MDA-T-PASP01.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
912165.80
Global Fund disbursement to MDA-T-PASP01.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
543508.32
Global Fund disbursement to MDA-T-PASP01.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
943123.52
Global Fund disbursement to MDA-T-PASP01.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
2688612.29
Global Fund disbursement to MDA-T-PASP01.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
593216.31
Global Fund disbursement to MDA-T-PASP01.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
-277306.35
Global Fund disbursement to MDA-T-PASP01.
Center for Health Policies and Studies (PAS Center)
The Global Fund to Fight AIDS, Tuberculosis and Malaria
<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
An overview of a grant over it's lifetime.
<narrative xml:lang="en">Grant terms and conditions.</narrative>
General terms and conditions which apply to Global Fund grants.
<narrative xml:lang="en">Coverage / Output indicators targets and results for MDA-T-PASP01</narrative>
<narrative xml:lang="en">MDR TB-other 4 : Percentage of new and relapse TB patients tested using WHO recomennded rapid tests at the time of diagnosis</narrative>
<narrative xml:lang="en">MDR TB-other 1 : Number and percentage of new MDR-TB patients transferred to or initiated DOTS Plus treatment on ambulatory phase and provided with incentives to improve treatment compliance</narrative>
<narrative xml:lang="en">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
<narrative xml:lang="en">Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
<narrative xml:lang="en">MDR TB-other 2 : Number and percentage of new sensitive TB patients transferred to or initiated DOTS treatment on ambulatory level, provided with incentives to improve treatment compliance (Transnistria)</narrative>
<narrative xml:lang="en">Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative>
<narrative xml:lang="en">Outcome indicators targets and results for MDA-T-PASP01</narrative>
<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
<narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
<narrative xml:lang="en">Impact indicators targets and results for MDA-T-PASP01</narrative>
<narrative xml:lang="en">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB patients with RR-TB and/or MDR-TB</narrative>
<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
47045-MDA-T-PAS-2
The Global Fund to Fight AIDS, Tuberculosis and Malaria
<narrative xml:lang="en">Strengthening Tuberculosis control in the Republic of Moldova - Moldova (01-Jan-2018-31-Dec-2020)</narrative>
Moldova, Tuberculosis, Center for Health Policies and Studies (PAS Center)This program has the following goals: To reduce the burden of tuberculosis (including M/XDR-TB) in Moldova by ensuring universal access to quality diagnosis and treatment, implementing sustainable patient-centered approaches, addressing the needs of high-risk groups and strengthening NTP management. The objectives of this program are: To ensure universal access to timely and quality diagnosis of all forms of TB inclusing MDR/XDR TB. To strenghten patient-centered approaches to MDR/XDR treatment. To improve management of HIV-associated TB
The Global Fund to Fight AIDS, Tuberculosis and Malaria
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies
Center for Health Policies and Studies
Center for Health Policies and Studies
The Global Fund to Fight AIDS, Tuberculosis and Malaria
The Global Fund to Fight AIDS Tuberculosis and Malaria
Communications
Web Team
+41 58 791 1700
website@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
The Global Fund to Fight AIDS Tuberculosis and Malaria
Grant Management Division
Tatiana, VINICHENKO
Fund Portfolio Manager
+41 58 791 1700
tatiana.vinichenko@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
The Global Fund to Fight AIDS Tuberculosis and Malaria
Communications
Web Team
+41 58 791 1700
website@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
Moldova
Multicomponent
Tuberculosis
Multicomponent -> Program management -> Grant management
Tuberculosis -> MDR-TB -> Case detection and diagnosis (MDR-TB)
Tuberculosis -> MDR-TB -> Collaborative activities with other programs and sectors (MDR-TB)
Tuberculosis -> MDR-TB -> Community MDR-TB care delivery
Tuberculosis -> MDR-TB -> Key populations (MDR-TB) - Others
Tuberculosis -> MDR-TB -> Prevention (MDR-TB)
Tuberculosis -> MDR-TB -> Treatment (MDR-TB)
1688196.44
1088431.53
1668013.56
-273.67
Global Fund Commitment to MDA-T-PASP02.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
1908033.41
Global Fund Commitment to MDA-T-PASP02.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
273.67
Global Fund Commitment to MDA-T-PASP02.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
2529923.20
Global Fund Commitment to MDA-T-PASP02.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
-17963.95
Global Fund Commitment to MDA-T-PASP02.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
-17963.95
Global Fund disbursement to MDA-T-PASP02.
Center for Health Policies and Studies (PAS Center)
The Global Fund to Fight AIDS, Tuberculosis and Malaria
407416.68
Global Fund disbursement to MDA-T-PASP02.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
388847.00
Global Fund disbursement to MDA-T-PASP02.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
454289.08
Global Fund disbursement to MDA-T-PASP02.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
682202.93
Global Fund disbursement to MDA-T-PASP02.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
365935.87
Global Fund disbursement to MDA-T-PASP02.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
432953.65
Global Fund disbursement to MDA-T-PASP02.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
381931.09
Global Fund disbursement to MDA-T-PASP02.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
357890.25
Global Fund disbursement to MDA-T-PASP02.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
353116.07
Global Fund disbursement to MDA-T-PASP02.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
613374.00
Global Fund disbursement to MDA-T-PASP02.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Center for Health Policies and Studies (PAS Center)
<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
An overview of a grant over it's lifetime.
<narrative xml:lang="en">Grant terms and conditions.</narrative>
General terms and conditions which apply to Global Fund grants.
<narrative xml:lang="en">Coverage / Output indicators targets and results for MDA-T-PASP02</narrative>
<narrative xml:lang="en">Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
<narrative xml:lang="en">Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative>
<narrative xml:lang="en">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
<narrative xml:lang="en">Outcome indicators targets and results for MDA-T-PASP02</narrative>
<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
<narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
<narrative xml:lang="en">TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed</narrative>
<narrative xml:lang="en">Impact indicators targets and results for MDA-T-PASP02</narrative>
<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
<narrative xml:lang="en">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB patients with RR-TB and/or MDR-TB</narrative>